

IPAMORELIN 5 MG INJECTION
Drug Class: Injectable
Composition:
- Active Substance: Ipamorelin
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Peptide Hubs
Tested in Laboratory: View Lab Report
Ipamorelin is a selective growth hormone-releasing peptide (GHRP) known for its effectiveness in boosting GH levels without significantly impacting cortisol or prolactin. It's widely studied for anti-aging, muscle recovery, fat metabolism, and sleep improvement. This 2 mL vial contains 5 mg of Ipamorelin, offered by Peptide Hubs for research purposes in the USA.
Ipamorelin works by mimicking ghrelin and binding to the growth hormone secretagogue receptor (GHS-R1a), triggering a natural pulse of GH from the pituitary. Unlike earlier GHRPs like GHRP-6, it avoids unwanted side effects such as appetite spikes or cortisol elevation. As supported by this NIH-published review on peptide-based therapeutics, Ipamorelin is recognized for its safety profile and tissue-selective action.
For enhanced regenerative support, researchers often stack Ipamorelin with BPC-157 or GHK-CU. To amplify GH signaling, it's frequently combined with CJC-1295 DAC.
Ipamorelin is typically administered subcutaneously at doses ranging from 100–300 mcg per day. Research cycles often span 8–12 weeks. When investigating GH-releasing synergies, it may also be used alongside IGF-1 LR3 or Epitalon.
This research compound is sourced from a respected US supplier of premium peptides. Below is the third-party lab test confirming strength and quality as of April 22, 2025:
Ipamorelin is used in research to stimulate natural growth hormone (GH) release. It is commonly studied for applications in muscle growth, fat loss, tissue healing, and anti-aging support.
Ipamorelin mimics the hunger hormone ghrelin and binds to GHS-R1a receptors, causing the pituitary gland to release growth hormone in a controlled, natural pulse—without increasing cortisol or prolactin.
Typical research dosages range from 100 mcg to 300 mcg per day, administered via subcutaneous injection. Research cycles often last 8 to 12 weeks.
Yes. Ipamorelin is often stacked with CJC-1295 DAC, BPC-157, or IGF-1 LR3 to enhance recovery, tissue repair, and growth hormone synergy in research settings.
Yes, Ipamorelin is legal for research use in the United States and is available through licensed suppliers such as Peptide Hubs.
Please log in to write Ipamorelin 5 mg review.
IPAMORELIN 5 MG INJECTION
Drug Class: Growth Hormone Secretagogue (GHS)
Composition:
- Active Substance: Ipamorelin
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
PENTADECAPEPTIDE 2 MG INJECTION
Drug Class: Healing/Repair Peptide
Composition:
- Active Substance: Pentadecapeptide
- Concentration: 5 mg/vial
Presentation: 5 mL Vial
Form: Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report